Showing results (91-100 of 190) with videos related to
Sort By:
Pageof 19
Targeted Oncology|September 25, 2015
Effect of Renal Impairment on the Pharmacokinetics and Safety of AxitinibYing Chen, Brian I Rini, Robert J Motzer, et al.Cancer|June 16, 2009
Analysis of PTEN and HIF-1alpha and correlation with efficacy in patients with advanced renal cell carcinoma treated with temsirolimus versus interferon-alphaRobert A Figlin, Paul de Souza, David McDermott, et al.Leukemia & Lymphoma|October 21, 2003
A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486)Peter H Wiernik, Peter A Cassileth, Traci Leong, et al.American Journal of Therapeutics|November 1, 1996
Phase II Trial of Paclitaxel in Patients with Advanced Colon Cancer Previously Untreated with Cytotoxic Chemotherapy: An Eastern Cooperative Oncology Group Trial (PA286)Avi I. Einzig, Donna Neuberg, Peter H. Wiernik, et al.Investigational New Drugs|January 4, 2020
NCI 6896: a phase I trial of vorinostat (SAHA) and isotretinoin (13-cis retinoic acid) in the treatment of patients with advanced renal cell carcinomaAna M Molina, Johannes C van der Mijn, Paul Christos, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2021
Plasma KIM-1 Is Associated with Recurrence Risk after Nephrectomy for Localized Renal Cell Carcinoma: A Trial of the ECOG-ACRIN Research Group (E2805)Wenxin Xu, Mäneka Puligandla, Brian Halbert, et al.Medical Oncology (Northwood, London, England)|January 29, 2010
Detection of a new embryonic antigen (ESA-10) in the blood of patients with cancer: preliminary results in the United StatesPeter H Wiernik, Dahlia Elkadi, Alvaro Luongo-Cespedes, et al.Journal of Clinical Pharmacology|April 5, 2013
Axitinib in metastatic renal cell carcinoma: results of a pharmacokinetic and pharmacodynamic analysisBrian I Rini, May Garrett, Bill Poland, et al.American Journal of Clinical Oncology|August 7, 2003
Phase II trial of infusional cyclophosphamide, idarubicin, and etoposide in poor prognosis non-Hodgkin's lymphomaHuda Salman, Alejandra Perez, Joseph A Sparano, et al.Cancer|September 16, 2008
Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma: a phase II Cytokine Working Group studyMichael B Atkins, Jeffrey A Sosman, Sanjiv Agarwala, et al.Pageof 19